Dong-A Of S. Korea Sells 9.9 Percent Stake To GSK Of U.K.
This article was originally published in PharmAsia News
Executive Summary
Korea's Dong-A Pharmaceutical is getting a $114.4 million infusion from U.K-based GlaxoSmithKline, which is buying a nearly 10 percent stake in the firm